Cardiac troponin is a marker of cardiac injury, enabling clinicians to aid in the diagnosis of myocardial infarction. Dr. Apple describes how new IFCC recommendations and guidelines for implementing high-sensitivity cardiac troponin assays will improve cardiac triage and patient outcomes worldwide.
New IFCC Task Force on Cardiac Biomarker Guidelines; Impact on Patient Care
|2019-05-02
